Send feedback

ABCA3 p.Glu292Val

c.875A>T · rs149989682 · VCV203381

Pathogenic/Likely pathogenic Multiple submitters
Classification
Pathogenic/Likely pathogenic
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 28 submitters
AlphaMissense
likely pathogenic
0.7033 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.579%, nfe)
Missense predictors
2/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
4
ABCA3-related disorder

Computational evidence

Protein change
AlphaMissense0.7033likely pathogenic ✓ concordant with ClinVar
REVEL0.949strongly pathogenic-leaning
SaProtLLR -7.95tolerated
⇒ AlphaMissense and REVEL call this damaging; SaProt does not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.8GERP 1.7, phastCons 1
Regional constrainto/e 0.98unconstrained · MANE · 40 kb · p 0.47 · regional, not allelic
Overall
CADD31.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.579% European (non-Finnish) · 6,829/1,179,822 alleles
Filtering AF 0.567% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.563%
Overall 0.453% 7,316/1,613,934 alleles · rare
Ancestry group Frequency 1 in
Amishnot grpmax-eligible 1.75% 57
European (non-Finnish)grpmax 0.579% 173
Remaining individualsnot grpmax-eligible 0.386% 259
Admixed American 0.172% 583
African / African-American 0.0959% 1,043
Finnishnot grpmax-eligible 0.0719% 1,392
Middle Eastern 0.0166% 6,040
South Asian 0.00659% 15,181
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,600
East Asian 0.00223% 44,872

Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ABCA3
Protein
p.Glu292Val
Coding
c.875A>T
MANE Select
NM_001089
dbSNP
rs149989682
Type
single nucleotide variant
Location
chr16:2317763 (GRCh38)
Gene constraint
LOEUF 0.612 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 81.00 · 2 PDB
Residue 292
a UniProt-annotated variant site (in smdp3; uncertain significance; does not affect lamellar bodies membrane location; does not affect proteolytic cleavage; affects lamellar bodies formation; does not affect cholesterol and phosphatidylcholine transport; decreases vesicles formation; does not affect free cholesterol induced cell death); an α-helix
Full ABCA3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/abca3-p-glu292val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown